MoonLake Immunotherapeutics
MLTXLatest QuantConomy context for MLTX: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
MoonLake Immunotherapeutics
QuantConomy has a structured record for MLTX. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- MLTX
- Name
- MoonLake Immunotherapeutics
- Coverage
- 3 market/data records
- Sources
- alpaca fmp alphavantage sec nasdaq
Recent signals for MLTX
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| standard proposed sale | slightly bearish | 34 | Jun 30, 09:50 PM | Santos da Silva Jorge filed Form 144 to sell MLTX shares ($3.00M) - 150,000 shares - expected around 6/30/2026 - [very weak slightly bearish signal - supply pressure] |
| passive decrease | neutral | 61 | Jun 30, 03:15 AM | BIOTECHNOLOGY VALUE FUND L P decreased passive stake in MLTX from 22.30% to 19.70% - (13G - passive investment) - 16,001,284 shares - [moderate neutral signal] |
| material agreement | bullish | 75 | Jun 25, 11:00 AM | MLTX filed 8-K: Material Definitive Agreement - 1 material event - [strong bullish signal] |
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
PROPOSED_SALE signals are experimental: historical Form 144 coverage is still being backfilled, so results may be sparse or empty.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| MLTX | NASDAQ | alpaca | MoonLake Immunotherapeutics Class A Ordinary Shares |
| MLTX | NASDAQ | fmp | MoonLake Immunotherapeutics |
| MLTX | NASDAQ | alphavantage | MoonLake Immunotherapeutics - Class A |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | Bodenstedt Matthias | Chief Financial Officer | sale | 39,120 | $22.04 | $862,205 | 4 on EDGAR |
| Jun 17, 2026 | Bodenstedt Matthias | Chief Financial Officer | sale | 15,082 | $19.68 | $296,814 | 4 on EDGAR |
| Jun 17, 2026 | BVF PARTNERS L P/IL | Insider | grant | 22,195 | — | — | 4 on EDGAR |
| Jun 17, 2026 | Xavier Ramnik | Insider | grant | 22,195 | — | — | 4 on EDGAR |
| Jun 17, 2026 | Loy Spike | Insider | grant | 22,195 | — | — | 4 on EDGAR |
| Jun 15, 2026 | Reich Kristian | Chief Scientific Officer | sale | 50,000 | $18.89 | $944,500 | 4 on EDGAR |
| May 11, 2026 | Bodenstedt Matthias | Chief Financial Officer | sale | 13,653 | $20.02 | $273,333 | 4 on EDGAR |
| Apr 14, 2026 | Bodenstedt Matthias | Chief Financial Officer | sale | 2,426 | $19.56 | $47,453 | 4 on EDGAR |
| Apr 10, 2026 | Santos da Silva Jorge | Chief Executive Officer | sale | 98,127 | $18.41 | $1,806,518 | 4 on EDGAR |
| Apr 9, 2026 | Bodenstedt Matthias | Chief Financial Officer | sale | 85,870 | $18.94 | $1,626,378 | 4 on EDGAR |
| Mar 31, 2026 | BVF PARTNERS L P/IL | Insider | sale | 1,932,354 | $16.79 | $32,444,224 | 4 on EDGAR |
| Jan 7, 2026 | Reich Kristian | Chief Scientific Officer | grant | 520,342 | — | — | 4 on EDGAR |
| Jan 7, 2026 | Santos da Silva Jorge | Chief Executive Officer | grant | 520,342 | — | — | 4 on EDGAR |
| Jan 7, 2026 | Bodenstedt Matthias | Chief Financial Officer | grant | 354,296 | $0.00 | $0 | 4 on EDGAR |
| Dec 19, 2025 | Bodenstedt Matthias | Chief Financial Officer | other | 294,473 | — | — | 4 on EDGAR |
| Dec 19, 2025 | Santos da Silva Jorge | Chief Executive Officer | other | 196,316 | — | — | 4 on EDGAR |
| Dec 19, 2025 | Reich Kristian | Chief Scientific Officer | other | 35,389 | — | — | 4 on EDGAR |
| Dec 8, 2025 | Santos da Silva Jorge | Chief Executive Officer | sale | 130,000 | $15.08 | $1,960,400 | 4 on EDGAR |
| Dec 8, 2025 | Reich Kristian | Chief Scientific Officer | sale | 130,000 | $15.08 | $1,960,400 | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query MLTX context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access